Results 51 to 60 of about 21,348 (217)

Athletic Intervention After Thoracic Surgery for Lung Cancer: Rationale and Design of the ATHENA Study

Health Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background The optimal therapeutic approach for early‐stage NSCLC (I–II, and, in some specific cases, IIIa) is lung resective surgery with mediastinal lymphadenectomy. However, it should be remarked that lung resection surgery further negatively affects respiratory muscle function and health‐related quality of life (HRQoL).
Giulia M. Stella, Francesco Bertuccio, Tiziano Gemelli, Matteo Fortunati, Oscar Crisafulli, Mitela Tafa, Amelia Grosso, Annalisa Di Silvestri, Giulio Melloni, Angelo G. Corsico, Giuseppe D'Antona   +10 more
wiley   +1 more source

Two-port right VATS pneumonectomy

, 2020
A video-assisted right pneumonectomy is a challenging but feasible procedure in expert hands. This video tutorial presents in detail the indications for and the individual surgical steps needed to safely perform a biportal video-assisted right ...
Dell'Amore A., Ciarrocchi A., Stella F., Campisi A.   +3 more
core   +1 more source

Pneumonectomy for Non-Small Cell Lung Cancer: Differences in Complications and Survival Based on the Side of Resection

Инновационная медицина Кубани
Background: Pneumonectomy remains a necessary intervention for certain patients with locally advanced non-small cell lung cancer (NSCLC); however, the prognostic significance of surgical side remains controversial.
E. A. Toneev, S. Yu. Pushkin, A. E. Slugin, G. K. Glazkov, M. S. Rudenko, N. D. Krymzalova, E. V. Chernetsov   +6 more
doaj   +1 more source

A Multi‐Stage Drop‐the‐Loser Design With Superiority Boundaries

Statistics in Medicine, Volume 45, Issue 15-17, July 2026.
ABSTRACT Multi‐arm multi‐stage (MAMS) trials have gained popularity, due to their improved efficiency in evaluating multiple treatments. A traditional MAMS trial often decreases the expected sample size of the trial compared with just running a multi‐arm approach, but with the drawback of an increase in maximum sample size.
Peter Greenstreet, Manel Khan, Salmaan Kanji, Pouya Motazedian, Andrew Seely, Stephanie Sibley, Tim Ramsay   +6 more
wiley   +1 more source

A pneumonectomy model to study flow-induced pulmonary hypertension and compensatory lung growth

Cell Reports: Methods, 2023
Summary: In newborns, developmental disorders such as congenital diaphragmatic hernia (CDH) and specific types of congenital heart disease (CHD) can lead to defective alveolarization, pulmonary hypoplasia, and pulmonary arterial hypertension (PAH ...
Savas T. Tsikis, Timothy Klouda, Thomas I. Hirsch, Scott C. Fligor, Tiffany Liu, Yunhye Kim, Amy Pan, Mikayla Quigley, Paul D. Mitchell, Mark Puder, Ke Yuan   +10 more
doaj   +1 more source

Single-Cell Transcriptional Profiling of Cells Derived From Regenerating Alveolar Ducts

Frontiers in Medicine, 2020
Lung regeneration occurs in a variety of adult mammals after surgical removal of one lung (pneumonectomy). Previous studies of murine post-pneumonectomy lung growth have identified regenerative “hotspots” in subpleural alveolar ducts; however, the cell ...
Alexandra B. Ysasi, Robert D. Bennett, Willi Wagner, Cristian D. Valenzuela, Andrew B. Servais, Akira Tsuda, Saumyadipta Pyne, Shuqiang Li, Jonna Grimsby, Prapti Pokharel, Kenneth J. Livak, Maximilian Ackermann, Paul C. Blainey, Paul C. Blainey, Steven J. Mentzer   +14 more
doaj   +1 more source

The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA–IIIB Non‐Small Cell Lung Cancer in Real‐World Practice

Thoracic Cancer, Volume 17, Issue 13, July 2026.
A low pre‐treatment NLR predicts better pathological response, higher surgical resection rate, and superior survival outcomes in patients with stage IIA–IIIB NSCLC receiving neoadjuvant immunochemotherapy, without compromising safety. NLR may serve as a readily available biomarker to guide clinical decision‐making.
Di Meng, Jiacong Liu, Gaoqi Ye, Linhai Zhu, Xuhua Huang, Xiayi Lv, Jian Hu   +6 more
wiley   +1 more source

Lung Cancer Surgery Part E: Pneumonectomy

, 2021
The aim of surgical treatment of non-small cell lung cancer is complete resection. Lately, the number of patients in whom pneumonectomy is necessary is decreasing attributable to advances in diagnostic imaging and improved techniques for surgery such as ...
Kaynak, Kamil, Demirkaya, Ahmet, Ersen, Ezel   +2 more
core  

Laparoscopic cholecystectomy in a patient with pneumonectomy

, 2020
Post pneumonectomy patients pose a challenge to the anaesthetist owing to the altered respiratory mechanics and decreased respiratory reserve. Performing laparoscopic surgery in such patients further deteriorates the already compromised lung functions ...
Chandel, Ankita, Sharma, Nisha, Kanwar, Manjit Singh   +2 more
core   +1 more source

A case series of VATS intrapericardial pneumonectomy: a bi-centric experience

Journal of Cardiothoracic Surgery
Background Intrapericardial pneumonectomy is a complex procedure indicated for large lung tumors where safe dissection of major vascular structures outside the pericardium is unfeasible or when the pericardium itself is invaded. Traditionally managed via
Güntuğ Batıhan, Kenan Can Ceylan
doaj   +1 more source